Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug addiction
Pharma
Reworked OxyContin hasn't reduced opioid abuse, FDA panel says
Purdue's reformulated OxyContin may stop patients from snorting or injecting the drug, but it doesn't curb abuse overall, an FDA panel determined.
Fraiser Kansteiner
Sep 21, 2020 12:58pm
Distributor stops opioid sales after being hit with $20M penalty
Jan 15, 2020 9:58am
J&J to avoid bellwether opioid trial with $20M settlement
Oct 2, 2019 10:15am
Publicis innovation contest crowns intranasal device as winner
Jul 17, 2019 10:17am
New Hampshire lawsuit slaps Purdue for overhyping opioids
Aug 9, 2017 9:23am
FDA plans to expand pharma's opioid-education duties
Jul 12, 2017 10:14am
